Showing results (41-50 of 123) with videos related to
Sort By:
Pageof 13
Urology|January 18, 2006
Is there a role for alpha1-blockers in treating double-J stent-related symptoms?Charalambos Deliveliotis, Michael Chrisofos, Evagelos Gougousis, et al.Expert Opinion on Pharmacotherapy|July 12, 2021
Overview of Olaparib as a treatment option for metastatic castration-resistant prostate cancerPanagiotis Mourmouris, Athanasios Papatsoris, Athanasios Dellis, et al.Urological Research|January 9, 2009
Ureteric guidewire damage by Holmium:YAG laser: preliminary resultsJonathan Reeves, Tamer El Husseiny, Athanasios Papatsoris, et al.Expert Opinion on Pharmacotherapy|June 2, 2021
A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancerMohamad Moussa, Athanasios Papatsoris, Despoina Sryropoulou, et al.Expert Opinion on Pharmacotherapy|August 7, 2023
An overview of hormonal directed pharmacotherapy for the treatment of prostate cancerMaria Mitsogianni, Athanasios Papatsoris, Vanessa-Meletia Bala, et al.Urolithiasis|June 8, 2013
The current role of percutaneous chemolysis in the management of urolithiasis: review and resultsStefanos Kachrilas, Athanasios Papatsoris, Christian Bach, et al.Journal of Endourology|May 24, 2008
Material fatigue testing of a new intraureteral wire stent (Zebrastent)Dimitrios Staios, Mayur Patel, Athanasios Papatsoris, et al.Arab Journal of Urology|December 14, 2017
Minimal surgical management of penile paraffinoma after subcutaneous penile paraffin injectionAthanasios E Dellis, Konstantinos Nastos, Demetrios Mastorakos, et al.Arab Journal of Urology|May 29, 2015
How to conduct a successful workshop: The trainees' perspectiveMichail Christodoulou, Stefanos Kachrilas, Ahmed Dina, et al.Asian Journal of Urology|February 24, 2022
Atypical small acinar proliferation and its significance in pathological reports in modern urological timesGeorgios Tsampoukas, Victor Manolas, Dominic Brown, et al.Pageof 13